NexMed Adds Execs

San Diego-based NexMed, a specialty contract research organization, announced earlier this week that it has named Terry Ladd as Vice President of Business Development at its Bio-Quant subsidiary, and Richard Martin as Vice President of Chemistry. Ladd has previously served at Calvert Laboratories, MDS Pharma Services, SkeleTech, Phoenix International Life Sciences, Chrysalis International, Pharmakon Research International, and ITR Laboratories. Martin was previously at RetroVirox, and also served at Exelixis/X-Ceptor Therapeutics, and Tanabe Research Laboratories.